Saum Sutaria, M.D.

Because the incremental dollars going straight into the current system, which I'm a participant in and everybody else, that's going to be necessary just because the population's aging. Fact of life, we're going to have more demand for roughly the next decade. But are we going to do that at the exclusion of resources into these other things? which in, again, in your language impacts healthspan.

Because the incremental dollars going straight into the current system, which I'm a participant in and everybody else, that's going to be necessary just because the population's aging. Fact of life, we're going to have more demand for roughly the next decade. But are we going to do that at the exclusion of resources into these other things? which in, again, in your language impacts healthspan.

In my language, it impacts the two things which sit in the background that seem to be different than the rest of the world, which is just basic nutrition and basic physical activity that seem to be major differences in how the US works versus others. Some of it because of geography, some of it because of our obsession with driving cars and whatever the case may be.

In my language, it impacts the two things which sit in the background that seem to be different than the rest of the world, which is just basic nutrition and basic physical activity that seem to be major differences in how the US works versus others. Some of it because of geography, some of it because of our obsession with driving cars and whatever the case may be.

It's not clear how we're going to approach that over the next decade because we don't have a choice but to spend for the people that are going to continue aging in. After 2032, 2033, if the pressure on the aging portion reduces, we may have some choices, but we got to get there first.

It's not clear how we're going to approach that over the next decade because we don't have a choice but to spend for the people that are going to continue aging in. After 2032, 2033, if the pressure on the aging portion reduces, we may have some choices, but we got to get there first.

So you and I used to mark our birth years roughly sometime in the 70s and talk about what the prevalence of diabetes or obesity was then relative to now. It's what, three, four fold up?

So you and I used to mark our birth years roughly sometime in the 70s and talk about what the prevalence of diabetes or obesity was then relative to now. It's what, three, four fold up?

Much more than.

Much more than.

We've talked about it. I mean, it's a generational failure of nutritional science to really understand what creates obesity and its sequela.

We've talked about it. I mean, it's a generational failure of nutritional science to really understand what creates obesity and its sequela.

I generally agree that these drugs are very effective. I get concerned about muscle loss in particular when I think about consequences for elderly people, especially from an orthopedic. Everybody knows that a hip fracture or whatever due to muscle loss creates a very high degree of mortality. But in general, I agree with the concept that these drugs are very effective.

I generally agree that these drugs are very effective. I get concerned about muscle loss in particular when I think about consequences for elderly people, especially from an orthopedic. Everybody knows that a hip fracture or whatever due to muscle loss creates a very high degree of mortality. But in general, I agree with the concept that these drugs are very effective.

Now, if you look at this from a crass economic point of view, remember, what's the fundamental problem we have in terms of generating the wealth to pay for the system is that we've moved from a period where we had twice the number of economically productive people from 40 to 65 and above to now the ratio approaching one to one.

Now, if you look at this from a crass economic point of view, remember, what's the fundamental problem we have in terms of generating the wealth to pay for the system is that we've moved from a period where we had twice the number of economically productive people from 40 to 65 and above to now the ratio approaching one to one.

So the best application of the drugs, if the idea is to improve health status, which then could improve economic productivity to support the system, would be applying them to the people who could still work, not the people over 65. Not that people can't work over 65, but generally, if you take that as a mindset of a period of retirement.

So the best application of the drugs, if the idea is to improve health status, which then could improve economic productivity to support the system, would be applying them to the people who could still work, not the people over 65. Not that people can't work over 65, but generally, if you take that as a mindset of a period of retirement.

I think if you're looking at it from the perspective of today's conversation around the cost of the U.S. healthcare system and how it interacts with the rest of the U.S. healthcare economy, that's the math.

I think if you're looking at it from the perspective of today's conversation around the cost of the U.S. healthcare system and how it interacts with the rest of the U.S. healthcare economy, that's the math.